What is Thermo Fisher Scientific Inc. (TMO)?

Thermo Fisher Scientific Inc. (TMO) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of TMO?

The current price of TMO is $708.36. Prices are updated in real time on Stocks360.

What is TMO's price-to-earnings (PE) ratio?

TMO's trailing twelve-month PE ratio is 37.30, based on current price and earnings per share data available on Stocks360.

What is TMO's market capitalization?

TMO's market capitalization is $261,914,187,511.00, placing it in the large-cap tier.

Does TMO pay a dividend?

Yes. TMO has a trailing twelve-month dividend yield of 0.00%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Thermo Fisher Scientific Inc. (TMO)

Stock analysis · NYSE · Healthcare · Medical - Diagnostics & Research

$708.36

Market Cap

$261.91B

PE (TTM)

37.30

EPS (TTM)

N/A

Dividend Yield

0.26%

Beta

0.88

Day Range

$691.03 – $710.91

52-wk Range

$435.27 – $710.91

Avg Volume

N/A

Volume

399.69K

Thermo Fisher Scientific Inc. (TMO) is a publicly traded company in the Healthcare sector. Latest price: $708.36. Market cap $261.91B. Trailing PE 37.30. Dividend yield 0.26%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $557.63 2026-10-28 · $709.59 (+27.25%)

Earnings

Most Recent

Oct 21, 2026

EPS $6.68 vs est. $6.40

Beat by $0.28

Next Earnings

Feb 4, 2027

EPS estimate $7.15

Proprietary Signals

Signal snapshot temporarily unavailable.

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laborator…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	37.30×
P/S (TTM)	5.53×
P/B	4.79×
PEG	3.92×
P/FCF (TTM)	34.48×
EV / EBITDA	26.49×
EV / Sales	6.29×
Earnings Yield	2.70%
Free Cash Flow Yield	2.90%
Dividend Yield	0.26%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$297.82B
Revenue (TTM)	$47.35B
Net Income (TTM)	$7.08B
Free Cash Flow (TTM)	$8.99B
Net Debt	$35.91B
Working Capital	$11.45B
Gross Margin	41.44%
Operating Margin	17.98%
Net Margin	14.96%
Return on Equity	13.31%
Return on Invested Capital	7.54%